This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:cancer [04.06.2019] – [Treatment for acute active Cancers] sallieq | home:diseases:cancer [05.16.2019] – [Other Immune Suppressants] sallieq | ||
---|---|---|---|
Line 23: | Line 23: | ||
* **liver cancer** – It is "well established" | * **liver cancer** – It is "well established" | ||
* **lung cancer** – According to a 2011 meta-analysis, | * **lung cancer** – According to a 2011 meta-analysis, | ||
- | * **prostate cancer** – In a 2005 culture-based study, Cohen found that // | + | * **prostate cancer** – In a 2005 culture-based study, Cohen found that // |
+ | * **Table of cancers** with associated agents. [[https:// | ||
With the recent advent of high throughput sequencing studies, we can expect additional insights into how diseases like cancer are associated with shifts in microbial communities. | With the recent advent of high throughput sequencing studies, we can expect additional insights into how diseases like cancer are associated with shifts in microbial communities. | ||
- | ==== see also M P Study Site Discussion | + | ==== see also M P Study Site ==== |
[[https:// | [[https:// | ||
Line 75: | Line 76: | ||
- | ==== Are There Concerns About Supplementing with Vitamin | + | ==== Are There Concerns About V.D Supplement |
There is a common misconception that vitamin D supplementation is safe at any reasonable level, or that if some is good, more may be better. | There is a common misconception that vitamin D supplementation is safe at any reasonable level, or that if some is good, more may be better. | ||
Line 87: | Line 88: | ||
Vitamin D receptor-mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis. (({{pubmed> | Vitamin D receptor-mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis. (({{pubmed> | ||
+ | |||
+ | 2014 a Cochrane meta-analysis that included 18 randomized clinical trials comparing vitamin D administration versus no intervention in healthy population found no difference regarding cancer incidence. | ||
====1, | ====1, | ||
Line 97: | Line 100: | ||
- | Women with hereditary breast cancer predispositions should | + | Women with hereditary breast cancer predispositions should |
Glioblastomas and malignant gliomas are the most common primary malignant brain tumors, with an annual incidence of 5.26 per 100,000 population. These tumors are typically associated with a dismal prognosis and poor quality of life. Only radiation exposure and certain genetic syndromes are well-defined risk factors for malignant glioma. | Glioblastomas and malignant gliomas are the most common primary malignant brain tumors, with an annual incidence of 5.26 per 100,000 population. These tumors are typically associated with a dismal prognosis and poor quality of life. Only radiation exposure and certain genetic syndromes are well-defined risk factors for malignant glioma. | ||
+ | |||
+ | This compound has antiproliferative and antimigratory effects in squamous cell carcinoma, glioblastoma, | ||
Several researchers have highlighted a possible link between glioma and human cytomegalovirus (HCMV). | Several researchers have highlighted a possible link between glioma and human cytomegalovirus (HCMV). | ||
Line 235: | Line 240: | ||
====Chemotherapy and radiation==== | ====Chemotherapy and radiation==== | ||
- | Chemotherapy is aggressively immunosuppressive, | + | Chemotherapy is aggressively immunosuppressive, |
==== Treatment for acute active Cancers==== | ==== Treatment for acute active Cancers==== | ||
Line 243: | Line 248: | ||
[[http:// | [[http:// | ||
+ | ==== Toll-like receptor 9 (TLR9) agonists ==== | ||
+ | |||
+ | The activity and safety of these novel anticancer agents are being explored in a wide range of tumor types as part of a variety of therapeutic strategies with the goal of harnessing the immune response to fight cancer. | ||
+ | |||
+ | Activation of Toll-Like Receptor 9 by DNA from Different Bacterial Species | ||
====Vaccines==== | ====Vaccines==== | ||
Line 251: | Line 261: | ||
//**Gene**, MarshallProtocol.com//</ | //**Gene**, MarshallProtocol.com//</ | ||
- | ====Vitamin D======== | + | ==== Vitamin D==== |
< | < | ||
Line 257: | Line 267: | ||
+ | === Vitamin E === | ||
+ | Vitamin E supplementation and the risk of heart failure in women. | ||
+ | (({{pubmed> | ||
+ | Supplementation with vitamin E did not result in any significant improvements in prognostic or functional indexes of heart failure or in the quality of life of patients with advanced heart failure.(({{pubmed> | ||
+ | |||
+ | Canolol was found to counteract the fibrotic effects of vitamin E + CoQ10 on cardiac fibrosis in the context of a high-fat diet enriched with RSO. This effect occurred through a restoration of cardiac Ag2R-1b mRNA expression and decreased ischemia.(({{pubmed> | ||
Line 269: | Line 285: | ||
Researchers trialling gene therapies against cancer have been unsuccessful to date. Such initiatives have yet to take into account the types of intracellular microbes implicated by the Marshall Pathogenesis. One, a Duke University program, to tailor cancer treatments to certain cancers [[http:// | Researchers trialling gene therapies against cancer have been unsuccessful to date. Such initiatives have yet to take into account the types of intracellular microbes implicated by the Marshall Pathogenesis. One, a Duke University program, to tailor cancer treatments to certain cancers [[http:// | ||
- | ==== Toll-like receptor 9 (TLR9) agonists ==== | ||
- | The activity and safety of these novel anticancer agents are being explored in a wide range of tumor types as part of a variety of therapeutic strategies with the goal of harnessing the immune response to fight cancer. | ||
- | |||
- | Activation of Toll-Like Receptor 9 by DNA from Different Bacterial Species | ||
=====Screening and diagnosis===== | =====Screening and diagnosis===== | ||
Line 362: | Line 374: | ||
===== Recent research ===== | ===== Recent research ===== | ||
- | |||
Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner. | Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner. | ||
- | |||
{{section>: | {{section>: | ||
Line 391: | Line 401: | ||
* [[https:// | * [[https:// | ||
* [[https:// | * [[https:// | ||
- | * [[http:// | + | * [[http:// |
* [[http:// | * [[http:// | ||